Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
https://www.zacks.com/stock/news/2261543/boston-scientific-bsx-q1-earnings-beat-estimates-view-raised?cid=CS-ZC-FT-analyst_blog|earnings_article-2261543
Apr 24, 2024 - Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter.
0
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
https://www.zacks.com/stock/news/2260506/what-s-in-store-for-these-4-medical-products-stocks-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2260506
Apr 23, 2024 - Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
0
Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2258362/unveiling-boston-scientific-bsx-q1-outlook-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2258362
Apr 19, 2024 - Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
0
Pages: 1
Page 1